▶ 調査レポート

デフェラシロクスのグローバル市場2021

• 英文タイトル:Global Deferasirox Sales Market Report 2021

QYResearchが調査・発行した産業分析レポートです。デフェラシロクスのグローバル市場2021 / Global Deferasirox Sales Market Report 2021 / QAF27637資料のイメージです。• レポートコード:QAF27637
• 出版社/出版日:QYResearch / 2021年4月1日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、130ページ
• 納品方法:Eメール(即日納品)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥600,000 (USD4,000)▷ お問い合わせ
  Multi User¥900,000 (USD6,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本市場調査資料では、世界のデフェラシロクス市場について種類別(500mg /錠、250mg /錠、125mg /錠、その他)、用途別(輸血による鉄過剰症、NTDTによる鉄過剰症)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・デフェラシロクス市場の概要
・世界の主要地域別デフェラシロクス市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界のデフェラシロクス市場規模2016-2021:種類別(500mg /錠、250mg /錠、125mg /錠、その他)
・世界のデフェラシロクス市場予測2012-2027:種類別(500mg /錠、250mg /錠、125mg /錠、その他)
・世界のデフェラシロクス市場規模2016-2021:用途別(輸血による鉄過剰症、NTDTによる鉄過剰症)
・世界のデフェラシロクス市場予測2012-2027:用途別(輸血による鉄過剰症、NTDTによる鉄過剰症)
・デフェラシロクスのアメリカ市場規模と予測2016-2021
・デフェラシロクスのヨーロッパ市場規模と予測2016-2021
・デフェラシロクスの中国市場規模と予測2016-2021
・デフェラシロクスの日本市場規模と予測2016-2021
・デフェラシロクスの東南アジア市場規模と予測2016-2021
・デフェラシロクスのインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Novartis、Cipla、Sun Pharma、Natco Pharma)
・デフェラシロクスの製造コスト分析
・販売チャネル、流通業者、顧客
・デフェラシロクスの市場動向・機会・課題
・調査の結論

Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias.
The half-life of deferasirox is between 8 and 16 hours allowing once a day dosing. Two molecules of deferasirox are capable of binding to 1 atom of iron which is subsequently eliminated by fecal excretion. Its low molecular weight and high lipophilicity allows the drug to be taken orally unlike deferoxamine which has to be administered by IV route (intravenous infusion). Together with deferiprone, deferasirox seems to be capable of removing iron from cells (cardiac myocytes and hepatocytes) as well as removing iron from the blood. Consumers are generally quick-change, to get or use newfangled products, better experience, better convenience and more quicker; to find and meet the needs of consumers, and exceeding expectation, better service.

Market Analysis and Insights: Global Deferasirox Market
The global Deferasirox market was valued at US$ 2729.8 in 2020 and will reach US$ 3554.9 million by the end of 2027, growing at a CAGR of 4.5% during 2022-2027.

Global Deferasirox Scope and Market Size
The global Deferasirox market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Deferasirox market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
500 mg/Tablet
250 mg/Tablet
125 mg/Tablet
Others

Segment by Application
Transfusional Iron Overload
NTDT Caused Iron Overload

The Deferasirox market is analysed and market size information is provided by regions (countries). Segment by Application, the Deferasirox market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Novartis
Cipla
Sun Pharma
Natco Pharma

レポート目次

1 Deferasirox Market Overview
1.1 Deferasirox Product Scope
1.2 Deferasirox Segment by Type
1.2.1 Global Deferasirox Sales by Type (2016 & 2021 & 2027)
1.2.2 500 mg/Tablet
1.2.3 250 mg/Tablet
1.2.4 125 mg/Tablet
1.2.5 Others
1.3 Deferasirox Segment by Application
1.3.1 Global Deferasirox Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Transfusional Iron Overload
1.3.3 NTDT Caused Iron Overload
1.4 Deferasirox Market Estimates and Forecasts (2016-2027)
1.4.1 Global Deferasirox Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Deferasirox Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Deferasirox Price Trends (2016-2027)

2 Deferasirox Estimates and Forecasts by Region
2.1 Global Deferasirox Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Deferasirox Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Deferasirox Sales Market Share by Region (2016-2021)
2.2.2 Global Deferasirox Revenue Market Share by Region (2016-2021)
2.3 Global Deferasirox Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Deferasirox Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Deferasirox Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Deferasirox Estimates and Projections (2016-2027)
2.4.2 Europe Deferasirox Estimates and Projections (2016-2027)
2.4.3 China Deferasirox Estimates and Projections (2016-2027)
2.4.4 Japan Deferasirox Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Deferasirox Estimates and Projections (2016-2027)
2.4.6 India Deferasirox Estimates and Projections (2016-2027)
3 Global Deferasirox Competition Landscape by Players
3.1 Global Top Deferasirox Players by Sales (2016-2021)
3.2 Global Top Deferasirox Players by Revenue (2016-2021)
3.3 Global Deferasirox Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Deferasirox as of 2020)
3.4 Global Deferasirox Average Price by Company (2016-2021)
3.5 Manufacturers Deferasirox Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Deferasirox Market Size by Type
4.1 Global Deferasirox Historic Market Review by Type (2016-2021)
4.1.1 Global Deferasirox Sales Market Share by Type (2016-2021)
4.1.2 Global Deferasirox Revenue Market Share by Type (2016-2021)
4.1.3 Global Deferasirox Price by Type (2016-2021)
4.2 Global Deferasirox Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Deferasirox Sales Forecast by Type (2022-2027)
4.2.2 Global Deferasirox Revenue Forecast by Type (2022-2027)
4.2.3 Global Deferasirox Price Forecast by Type (2022-2027)
5 Global Deferasirox Market Size by Application
5.1 Global Deferasirox Historic Market Review by Application (2016-2021)
5.1.1 Global Deferasirox Sales Market Share by Application (2016-2021)
5.1.2 Global Deferasirox Revenue Market Share by Application (2016-2021)
5.1.3 Global Deferasirox Price by Application (2016-2021)
5.2 Global Deferasirox Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Deferasirox Sales Forecast by Application (2022-2027)
5.2.2 Global Deferasirox Revenue Forecast by Application (2022-2027)
5.2.3 Global Deferasirox Price Forecast by Application (2022-2027)

6 North America Deferasirox Market Facts & Figures
6.1 North America Deferasirox Sales by Company
6.1.1 North America Deferasirox Sales by Company (2016-2021)
6.1.2 North America Deferasirox Revenue by Company (2016-2021)
6.2 North America Deferasirox Sales Breakdown by Type
6.2.1 North America Deferasirox Sales Breakdown by Type (2016-2021)
6.2.2 North America Deferasirox Sales Breakdown by Type (2022-2027)
6.3 North America Deferasirox Sales Breakdown by Application
6.3.1 North America Deferasirox Sales Breakdown by Application (2016-2021)
6.3.2 North America Deferasirox Sales Breakdown by Application (2022-2027)

7 Europe Deferasirox Market Facts & Figures
7.1 Europe Deferasirox Sales by Company
7.1.1 Europe Deferasirox Sales by Company (2016-2021)
7.1.2 Europe Deferasirox Revenue by Company (2016-2021)
7.2 Europe Deferasirox Sales Breakdown by Type
7.2.1 Europe Deferasirox Sales Breakdown by Type (2016-2021)
7.2.2 Europe Deferasirox Sales Breakdown by Type (2022-2027)
7.3 Europe Deferasirox Sales Breakdown by Application
7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)

8 China Deferasirox Market Facts & Figures
8.1 China Deferasirox Sales by Company
8.1.1 China Deferasirox Sales by Company (2016-2021)
8.1.2 China Deferasirox Revenue by Company (2016-2021)
8.2 China Deferasirox Sales Breakdown by Type
8.2.1 China Deferasirox Sales Breakdown by Type (2016-2021)
8.2.2 China Deferasirox Sales Breakdown by Type (2022-2027)
8.3 China Deferasirox Sales Breakdown by Application
8.3.1 China 245 Sales Breakdown by Application (2016-2021)
8.3.2 China 245 Sales Breakdown by Application (2022-2027)

9 Japan Deferasirox Market Facts & Figures
9.1 Japan Deferasirox Sales by Company
9.1.1 Japan Deferasirox Sales by Company (2016-2021)
9.1.2 Japan Deferasirox Revenue by Company (2016-2021)
9.2 Japan Deferasirox Sales Breakdown by Type
9.2.1 Japan Deferasirox Sales Breakdown by Type (2016-2021)
9.2.2 Japan Deferasirox Sales Breakdown by Type (2022-2027)
9.3 Japan Deferasirox Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Deferasirox Market Facts & Figures
10.1 Southeast Asia Deferasirox Sales by Company
10.1.1 Southeast Asia Deferasirox Sales by Company (2016-2021)
10.1.2 Southeast Asia Deferasirox Revenue by Company (2016-2021)
10.2 Southeast Asia Deferasirox Sales Breakdown by Type
10.2.1 Southeast Asia Deferasirox Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Deferasirox Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Deferasirox Sales Breakdown by Application
10.3.1 Southeast Asia M Tablets Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Tablets Sales Breakdown by Application (2022-2027)

11 India Deferasirox Market Facts & Figures
11.1 India Deferasirox Sales by Company
11.1.1 India Deferasirox Sales by Company (2016-2021)
11.1.2 India Deferasirox Revenue by Company (2016-2021)
11.2 India Deferasirox Sales Breakdown by Type
11.2.1 India Deferasirox Sales Breakdown by Type (2016-2021)
11.2.2 India Deferasirox Sales Breakdown by Type (2022-2027)
11.3 India Deferasirox Sales Breakdown by Application
11.3.1 India Deferasirox Sales Breakdown by Application (2016-2021)
11.3.2 India Deferasirox Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Deferasirox Business
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Business Overview
12.1.3 Novartis Deferasirox Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Deferasirox Products Offered
12.1.5 Novartis Recent Development
12.2 Cipla
12.2.1 Cipla Corporation Information
12.2.2 Cipla Business Overview
12.2.3 Cipla Deferasirox Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Cipla Deferasirox Products Offered
12.2.5 Cipla Recent Development
12.3 Sun Pharma
12.3.1 Sun Pharma Corporation Information
12.3.2 Sun Pharma Business Overview
12.3.3 Sun Pharma Deferasirox Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sun Pharma Deferasirox Products Offered
12.3.5 Sun Pharma Recent Development
12.4 Natco Pharma
12.4.1 Natco Pharma Corporation Information
12.4.2 Natco Pharma Business Overview
12.4.3 Natco Pharma Deferasirox Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Natco Pharma Deferasirox Products Offered
12.4.5 Natco Pharma Recent Development

13 Deferasirox Manufacturing Cost Analysis
13.1 Deferasirox Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Deferasirox
13.4 Deferasirox Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Deferasirox Distributors List
14.3 Deferasirox Customers

15 Market Dynamics
15.1 Deferasirox Market Trends
15.2 Deferasirox Drivers
15.3 Deferasirox Market Challenges
15.4 Deferasirox Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Deferasirox Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Deferasirox Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Deferasirox Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Deferasirox Sales (M Tablets) by Region (2016-2021)
Table 5. Global Deferasirox Sales Market Share by Region (2016-2021)
Table 6. Global Deferasirox Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Deferasirox Revenue Share by Region (2016-2021)
Table 8. Global Deferasirox Sales (M Tablets) Forecast by Region (2022-2027)
Table 9. Global Deferasirox Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Deferasirox Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Deferasirox Revenue Share Forecast by Region (2022-2027)
Table 12. Global Deferasirox Sales (M Tablets) of Key Companies (2016-2021)
Table 13. Global Deferasirox Sales Share by Company (2016-2021)
Table 14. Global Deferasirox Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Deferasirox Revenue Share by Company (2016-2021)
Table 16. Global Deferasirox by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Deferasirox as of 2020)
Table 17. Global Deferasirox Average Price (USD/Tablet) of Key Company (2016-2021)
Table 18. Manufacturers Deferasirox Manufacturing Sites and Area Served
Table 19. Manufacturers Deferasirox Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Deferasirox Sales (M Tablets) by Type (2016-2021)
Table 22. Global Deferasirox Sales Share by Type (2016-2021)
Table 23. Global Deferasirox Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Deferasirox Price (USD/Tablet) by Type (2016-2021)
Table 25. Global Deferasirox Sales Share by Type (2022-2027)
Table 26. Global Deferasirox Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Deferasirox Revenue Share by Type (2022-2027)
Table 28. Global Deferasirox Price (USD/Tablet) by Type (2022-2027)
Table 29. Global Deferasirox Sales (M Tablets) by Application (2016-2021)
Table 30. Global Deferasirox Sales Share by Application (2016-2021)
Table 31. Global Deferasirox Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Deferasirox Price (USD/Tablet) by Application (2016-2021)
Table 33. Global Deferasirox Sales (M Tablets) by Application (2022-2027)
Table 34. Global Deferasirox Sales Share by Application (2022-2027)
Table 35. Global Deferasirox Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Deferasirox Revenue Share by Application (2022-2027)
Table 37. Global Deferasirox Price (USD/Tablet) by Application (2022-2027)
Table 38. North America Deferasirox Sales (M Tablets) by Company (2016-2021)
Table 39. North America Deferasirox Sales Market Share by Company (2016-2021)
Table 40. North America Deferasirox Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Deferasirox Revenue Market Share by Company (2016-2021)
Table 42. North America Deferasirox Sales by Type (2016-2021) & (M Tablets)
Table 43. North America Deferasirox Sales Market Share by Type (2016-2021)
Table 44. North America Deferasirox Sales by Type (2022-2027) & (M Tablets)
Table 45. North America Deferasirox Sales Market Share by Type (2022-2027)
Table 46. North America Deferasirox Sales by Application (2016-2021) & (M Tablets)
Table 47. North America Deferasirox Sales Market Share by Application (2016-2021)
Table 48. North America Deferasirox Sales by Application (2022-2027) & (M Tablets)
Table 49. North America Deferasirox Sales Market Share by Application (2022-2027)
Table 50. Europe Deferasirox Sales (M Tablets) by Company (2016-2021)
Table 51. Europe Deferasirox Sales Market Share by Company (2016-2021)
Table 52. Europe Deferasirox Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Deferasirox Revenue Market Share by Company (2016-2021)
Table 54. Europe Deferasirox Sales by Type (2016-2021) & (M Tablets)
Table 55. Europe Deferasirox Sales Market Share by Type (2016-2021)
Table 56. Europe Deferasirox Sales by Type (2022-2027) & (M Tablets)
Table 57. Europe Deferasirox Sales Market Share by Type (2022-2027)
Table 58. Europe Deferasirox Sales by Application (2016-2021) & (M Tablets)
Table 59. Europe Deferasirox Sales Market Share by Application (2016-2021)
Table 60. Europe Deferasirox Sales by Application (2022-2027) & (M Tablets)
Table 61. Europe Deferasirox Sales Market Share by Application (2022-2027)
Table 62. China Deferasirox Sales (M Tablets) by Company (2016-2021)
Table 63. China Deferasirox Sales Market Share by Company (2016-2021)
Table 64. China Deferasirox Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Deferasirox Revenue Market Share by Company (2016-2021)
Table 66. China Deferasirox Sales by Type (2016-2021) & (M Tablets)
Table 67. China Deferasirox Sales Market Share by Type (2016-2021)
Table 68. China Deferasirox Sales by Type (2022-2027) & (M Tablets)
Table 69. China Deferasirox Sales Market Share by Type (2022-2027)
Table 70. China Deferasirox Sales by Application (2016-2021) & (M Tablets)
Table 71. China Deferasirox Sales Market Share by Application (2016-2021)
Table 72. China Deferasirox Sales by Application (2022-2027) & (M Tablets)
Table 73. China Deferasirox Sales Market Share by Application (2022-2027)
Table 74. Japan Deferasirox Sales (M Tablets) by Company (2016-2021)
Table 75. Japan Deferasirox Sales Market Share by Company (2016-2021)
Table 76. Japan Deferasirox Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Deferasirox Revenue Market Share by Company (2016-2021)
Table 78. Japan Deferasirox Sales by Type (2016-2021) & (M Tablets)
Table 79. Japan Deferasirox Sales Market Share by Type (2016-2021)
Table 80. Japan Deferasirox Sales by Type (2022-2027) & (M Tablets)
Table 81. Japan Deferasirox Sales Market Share by Type (2022-2027)
Table 82. Japan Deferasirox Sales by Application (2016-2021) & (M Tablets)
Table 83. Japan Deferasirox Sales Market Share by Application (2016-2021)
Table 84. Japan Deferasirox Sales by Application (2022-2027) & (M Tablets)
Table 85. Japan Deferasirox Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Deferasirox Sales (M Tablets) by Company (2016-2021)
Table 87. Southeast Asia Deferasirox Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Deferasirox Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Deferasirox Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Deferasirox Sales by Type (2016-2021) & (M Tablets)
Table 91. Southeast Asia Deferasirox Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Deferasirox Sales by Type (2022-2027) & (M Tablets)
Table 93. Southeast Asia Deferasirox Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Deferasirox Sales by Application (2016-2021) & (M Tablets)
Table 95. Southeast Asia Deferasirox Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Deferasirox Sales by Application (2022-2027) & (M Tablets)
Table 97. Southeast Asia Deferasirox Sales Market Share by Application (2022-2027)
Table 98. India Deferasirox Sales (M Tablets) by Company (2016-2021)
Table 99. India Deferasirox Sales Market Share by Company (2016-2021)
Table 100. India Deferasirox Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Deferasirox Revenue Market Share by Company (2016-2021)
Table 102. India Deferasirox Sales by Type (2016-2021) & (M Tablets)
Table 103. India Deferasirox Sales Market Share by Type (2016-2021)
Table 104. India Deferasirox Sales by Type (2022-2027) & (M Tablets)
Table 105. India Deferasirox Sales Market Share by Type (2022-2027)
Table 106. India Deferasirox Sales by Application (2016-2021) & (M Tablets)
Table 107. India Deferasirox Sales Market Share by Application (2016-2021)
Table 108. India Deferasirox Sales by Application (2022-2027) & (M Tablets)
Table 109. India Deferasirox Sales Market Share by Application (2022-2027)
Table 110. Novartis Corporation Information
Table 111. Novartis Description and Business Overview
Table 112. Novartis Deferasirox Sales (M Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 113. Novartis Deferasirox Product
Table 114. Novartis Recent Development
Table 115. Cipla Corporation Information
Table 116. Cipla Description and Business Overview
Table 117. Cipla Deferasirox Sales (M Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 118. Cipla Deferasirox Product
Table 119. Cipla Recent Development
Table 120. Sun Pharma Corporation Information
Table 121. Sun Pharma Description and Business Overview
Table 122. Sun Pharma Deferasirox Sales (M Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 123. Sun Pharma Deferasirox Product
Table 124. Sun Pharma Recent Development
Table 125. Natco Pharma Corporation Information
Table 126. Natco Pharma Description and Business Overview
Table 127. Natco Pharma Deferasirox Sales (M Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 128. Natco Pharma Deferasirox Product
Table 129. Natco Pharma Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Deferasirox Distributors List
Table 133. Deferasirox Customers List
Table 134. Deferasirox Market Trends
Table 135. Deferasirox Market Drivers
Table 136. Deferasirox Market Challenges
Table 137. Deferasirox Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Deferasirox Product Picture
Figure 2. Global Deferasirox Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Deferasirox Sales Market Share by Application in 2021 & 2027
Figure 6. Transfusional Iron Overload Examples
Figure 7. NTDT Caused Iron Overload Examples
Figure 8. Global Deferasirox Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Deferasirox Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Deferasirox Sales (M Tablets) Growth Rate (2016-2027)
Figure 11. Global Deferasirox Price Trends Growth Rate (2016-2027) (USD/Tablet)
Figure 12. Global Deferasirox Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Deferasirox Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Deferasirox Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Deferasirox Sales (M Tablets) Growth Rate (2016-2027)
Figure 16. Europe Deferasirox Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Deferasirox Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Deferasirox Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Deferasirox Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Deferasirox Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Deferasirox Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Deferasirox Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Deferasirox Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Deferasirox Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Deferasirox Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Deferasirox Players Market Share by Revenue in Deferasirox: 2016 & 2020
Figure 27. Deferasirox Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Deferasirox Revenue Share by Type (2016-2021)
Figure 29. Global Deferasirox Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Deferasirox Revenue Share by Application (2016-2021)
Figure 31. Global Deferasirox Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Deferasirox Sales Market Share by Type in 2020
Figure 33. North America Deferasirox Sales Market Share by Application in 2020
Figure 34. Europe Deferasirox Sales Market Share by Type in 2020
Figure 35. Europe Deferasirox Sales Market Share by Application in 2020
Figure 36. China Deferasirox Sales Market Share by Type in 2020
Figure 37. China Deferasirox Sales Market Share by Application in 2020
Figure 38. Japan Deferasirox Sales Market Share by Type in 2020
Figure 39. Japan Deferasirox Sales Market Share by Application in 2020
Figure 40. Southeast Asia Deferasirox Sales Market Share by Type in 2020
Figure 41. Southeast Asia Deferasirox Sales Market Share by Application in 2020
Figure 42. India Deferasirox Sales Market Share by Type in 2020
Figure 43. India Deferasirox Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Deferasirox
Figure 46. Manufacturing Process Analysis of Deferasirox
Figure 47. Deferasirox Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed